CurrentCardio
Get Weekly

CurrentCardio coverage · page 3 of 6

ESC Heart Failure

Briefs 81–120 of 214 CurrentCardio has covered from this journal, newest publication first

Latest from ESC Heart Failure

All coverage, newest first

  1. ESC Heart Fail

    Novel insights into the histopathological characteristics of immune checkpoint inhibitor-related myocarditis

    Cohort studyHeart failure

  2. ESC Heart Fail

    Sex-Dependent Fibroblast Signatures in Heart Failure: Toward Stratified Anti-Fibro-Inflammatory Therapies

    Research articleHeart failure

  3. ESC Heart Fail

    Adipokine profile in acute heart failure: associations with natriuretic response and prognosis

    Cohort studyHeart failure

  4. ESC Heart Fail

    Interplay between acute heart failure and COPD in patients hospitalized for dysponea: prognostic insights from the PARADISE cohort

    Cohort studyHeart failure

  5. ESC Heart Fail

    Left Ventricular Function and Atrial Remodeling Shape Outcomes After Mitral-Transcatheter Edge-to-Edge Repair

    Research articleValvular & structural

  6. ESC Heart Fail

    Stratifying prognosis in heart failure patients with reduced ejection fraction and atrial cardiomyopathy

    Cohort studyHeart failure

  7. ESC Heart Fail

    Impact of concomitant left-sided valve disease on outcomes following tricuspid valve transcatheter edge-to-edge repair: insights from EuroTR

    Cohort studyValvular & structural

  8. ESC Heart Fail

    Non-invasive quantification of haemodynamic imbalance in acute heart failure

    Mechanistic studyHeart failure

  9. ESC Heart Fail

    One-year multicenter prospective real-world study of vericiguat effectiveness and safety in Spain

    Cohort studyHeart failure

  10. ESC Heart Fail

    Cardiac magnetic resonance-derived left atrioventricular coupling index predicts outcome in reduced ejection fraction

    Cohort studyHeart failure

  11. ESC Heart Fail

    Characterization of incident heart failure after ischaemic stroke/transient ischaemic attack: a UK Biobank study

    Cohort studyHeart failure

  12. ESC Heart Fail

    Cost-effectiveness of TTVR with EVOQUE system in patients with Severe Tricuspid Regurgitation based on TRISCEND II trial

    Research articleValvular & structural

  13. ESC Heart Fail

    FEV1 is a major prognostic factor in diverse heart failure populations: findings from the Global Heart Failure registry

    Secondary analysisHeart failure

  14. ESC Heart Fail

    Apical myocardial fibrosis burden identifies a high-risk phenotype and predicts cardiac mortality after LVAD implantation

    Cohort studyHeart failure

  15. ESC Heart Fail

    Effect of anti-fibrotic therapy on regression of myocardial fibrosis after TAVI: design and rationale of the Reduce-MFA DZHK25 trial

    Trial designValvular & structural

  16. ESC Heart Fail

    Interaction of secondary ventricular tricuspid regurgitation with RV in HFREF: an invasive pressure-volume loop study

    Cohort studyHeart failure

  17. ESC Heart Fail

    Renal replacement therapy in type 2 severe cardiorenal syndrome: a randomized controlled trial

    Randomised controlled trialHeart failure

  18. ESC Heart Fail

    Low cardiovascular event rates in patients treated with CAR T-cells: Real-world outcomes from two independent cohorts

    Research articleCardio-oncology & other

  19. ESC Heart Fail

    Congestion and renal function in patients with chronic heart failure

    Research articleHeart failure

  20. ESC Heart Fail

    Diet–gut microbiota interaction Index and heart failure risk in diabetes and prediabetes: evidence from NHANES 2007–2018

    Cross-sectional studyCardiometabolic & kidney

  21. ESC Heart Fail

    Out-of-hours primary care management for patients with heart failure

    Research articleHeart failure

  22. ESC Heart Fail

    Real-world incidence of cancer therapy–related cardiac dysfunction in a large, diverse, and contemporary cohort

    Cohort studyCardio-oncology & other

  23. ESC Heart Fail

    Evaluation and management of recent onset cardiomyopathy in the current era of heart failure therapeutics: a clinical consensus statement of the Heart Failure Association of the ESC

    Guideline or statementHeart failure

  24. ESC Heart Fail

    Impact of routine urine sodium evaluation on diuretic practices in patients with acute heart failure

    Cohort studyHeart failure

  25. ESC Heart Fail

    Right ventricular free-wall strain-based risk stratification for temporary mechanical circulatory support in cardiogenic shock

    Cohort studyAcute care & resuscitation

  26. ESC Heart Fail

    The quantitative haemodynamic effect of levosimendan, dobutamine, and milrinone in heart failure patients: a meta-analysis

    Meta-analysisHeart failure

  27. ESC Heart Fail

    Inhibition of adenosine kinase alleviates hypertrophic cardiomyopathy by ameliorating coronary microvascular dysfunction

    Research articleHeart failure

  28. ESC Heart Fail

    Endothelial and inflammatory responses during ex vivo normothermic perfusion of human cardiac grafts

    Cohort studyHeart failure

  29. ESC Heart Fail

    Glucagon-like peptide-1 receptor agonists in patients with heart failure with reduced ejection fraction

    Cohort studyHeart failure

  30. ESC Heart Fail

    Home-based body water monitoring and management system for heart failure patients using bioelectrical impedance analysis

    Randomised controlled trialHeart failure

  31. ESC Heart Fail

    Prognosis of tricuspid regurgitation after mitral transcatheter edge-to-edge repair: the EXPANDed studies

    Cohort studyValvular & structural

  32. ESC Heart Fail

    Plasma protein profiles in different heart failure phenotypes

    Cohort studyHeart failure

  33. ESC Heart Fail

    Design, rationale, and baseline characteristics of the dapagliflozin in haemodialysis (DAPA-HD) trial

    Trial designCardiometabolic & kidney

  34. ESC Heart Fail

    Worse long-term outcomes in new-onset HFpEF vs HFrEF and HFmrEF: findings from the Stockholm PREFERS study

    Cohort studyHeart failure

  35. ESC Heart Fail

    An integrated Biobank in the Swedish Heart Failure Registry—clinomics, proteomics, transcriptomics and genomics

    Cohort studyHeart failure

  36. ESC Heart Fail

    CONFIDENT-HFpEF: a machine learning-based risk stratification for mortality and hospitalization using multimodal real-world data

    Cohort studyHeart failure

  37. ESC Heart Fail

    Invasive haemodynamic validation of an artificial intelligence echocardiographic tool for detecting heart failure with preserved ejection fraction

    Diagnostic or prognostic studyHeart failure

  38. ESC Heart Fail

    Association between functional Status and cardiac function in chronic heart failure: insights from the C-MIC II Trial

    Secondary analysisHeart failure

  39. ESC Heart Fail

    Acetazolamide effects on natriuresis and diuresis in acute heart failure treated with furosemide and SGLT2i (SANDI)

    Trial designHeart failure

  40. ESC Heart Fail

    Ten years real-world experience with sacubitril/valsartan in patients with heart failure with reduced ejection fraction

    Meta-analysisHeart failure

All 214 Briefs in ExploreShowing Briefs 81–120 of 214, newest first